Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Tuberous Sclerosis 3Epilepsy 1Child Development Disorders, Pervasive 1Autistic Disorder 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Activator Appliances × Clear all
NCT04698538 2024-10-30

TRAIN

University of California, Los Angeles

Phase NA Completed
54 enrolled

Tuberous Sclerosis

NCT03422367 2020-11-06

JETS

University of California, Los Angeles

Phase NA Unknown
64 enrolled

Autistic Disorder, Child Development Disorders, Pervasive, Epilepsy, Tuberous Sclerosis

NCT02687633 2018-05-02

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

University of California, Los Angeles

Phase NA Completed
8 enrolled

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡